The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6697935 7366962 I 6697935-6 20100301 20100420 20100427 PER US-BIOGENIDEC-2010BI013572 BIOGEN IDEC INC. 50 YR F Y 20100427 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6697935 1013573612 PS TYSABRI 1 INTRAVENOUS

Indications of drugs used

Event ID DRUG SEQ INDI PT
6697935 1013573612 MULTIPLE SCLEROSIS

Outcome of event

no results found

Reactions reported

Event ID PT
6697935 BIPOLAR DISORDER
6697935 CONFUSIONAL STATE
6697935 DEPRESSION
6697935 HYPOAESTHESIA FACIAL
6697935 SOMNOLENCE

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6697935 1013573612 20100105